Market Closed -
Other stock markets
|
After market 23:08:26 | |||
64.92 USD | -0.82% | 65.18 | +0.39% |
05-07 | Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates | MT |
05-02 | UBS Adjusts Price Target on Gilead Sciences to $70 From $75, Maintains Neutral Rating | MT |